Risks stratification and benefits of PCI: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 2: | Line 2: | ||
{{WikiDoc Cardiology Network Infobox}} | {{WikiDoc Cardiology Network Infobox}} | ||
'''Editor(s)-In-Chief:''' Xin Yang, MA(Cantab), MB BChir, MRCP(Lond) | '''Editor(s)-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond) | ||
==Risk Score Assessment== | ==Risk Score Assessment== | ||
Revision as of 17:05, 13 September 2011
| Cardiology Network |
 Discuss Risks stratification and benefits of PCI further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond)